相似文献
1
Cardiogenic shock: all hail the RCT, long live the registry.
Crit Care. 2024 Feb 19;28(1):53. doi: 10.1186/s13054-024-04835-0.
2
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
Cochrane Database Syst Rev. 2011 Jul 6(7):CD007398. doi: 10.1002/14651858.CD007398.pub2.
3
Aortic counterpulsation in cardiogenic shock during acute myocardial infarction.
Expert Rev Cardiovasc Ther. 2014 Jul;12(7):913-7. doi: 10.1586/14779072.2014.921116. Epub 2014 May 21.
4
Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
EuroIntervention. 2011 Aug;7(4):437-41. doi: 10.4244/EIJV7I4A72.
5
The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.
Am Heart J. 2001 Jun;141(6):933-9. doi: 10.1067/mhj.2001.115295.
6
Cardiogenic shock: to pump or not to pump?
Eur Heart J. 2009 Feb;30(4):389-90. doi: 10.1093/eurheartj/ehp030. Epub 2009 Jan 30.
7
Intra-aortic balloon pump in patients with cardiogenic shock complicating myocardial infarction: a systematic review and meta-analysis of randomized trials (protocol).
Syst Rev. 2014 Mar 12;3:24. doi: 10.1186/2046-4053-3-24.
8
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
J Am Coll Cardiol. 2000 Sep;36(3 Suppl A):1123-9. doi: 10.1016/s0735-1097(00)00875-5.
9
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Am Heart J. 2015 Apr;169(4):e7-8. doi: 10.1016/j.ahj.2015.01.009. Epub 2015 Jan 30.
10
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Am Heart J. 2012 Jun;163(6):938-45. doi: 10.1016/j.ahj.2012.03.012.
本文引用的文献
1
Extracorporeal Life Support Organization Registry International Report 2022: 100,000 Survivors.
ASAIO J. 2024 Feb 1;70(2):131-143. doi: 10.1097/MAT.0000000000002128. Epub 2024 Jan 5.
2
Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The National Cardiogenic Shock Initiative.
J Am Heart Assoc. 2023 Dec 5;12(23):e031401. doi: 10.1161/JAHA.123.031401. Epub 2023 Nov 28.
3
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).
Circulation. 2023 Oct 3;148(14):1113-1126. doi: 10.1161/CIRCULATIONAHA.123.064527. Epub 2023 Oct 2.
4
Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials.
Lancet. 2023 Oct 14;402(10410):1338-1346. doi: 10.1016/S0140-6736(23)01607-0. Epub 2023 Aug 26.
5
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial.
EuroIntervention. 2023 Aug 21;19(6):482-492. doi: 10.4244/EIJ-D-23-00204.
6
Cultivating the Research Landscape for Critical Care Cardiology: The Case for Registry-Based Randomized Controlled Trials.
Circulation. 2023 May 30;147(22):1637-1639. doi: 10.1161/CIRCULATIONAHA.122.060802.
7
The National Danish Cardiac Arrest Registry for Out-of-Hospital Cardiac Arrest - A Registry in Transformation.
Clin Epidemiol. 2022 Aug 8;14:949-957. doi: 10.2147/CLEP.S374788. eCollection 2022.
8
Three-year experience of catheter-based micro-axial left ventricular assist device, Impella, in Japanese patients: the first interim analysis of Japan registry for percutaneous ventricular assist device (J-PVAD).
J Artif Organs. 2023 Mar;26(1):17-23. doi: 10.1007/s10047-022-01328-1. Epub 2022 Apr 25.
9
Comparative Analysis of Patient Characteristics in Cardiogenic Shock Studies: Differences Between Trials and Registries.
JACC Cardiovasc Interv. 2022 Feb 14;15(3):297-304. doi: 10.1016/j.jcin.2021.11.036.
10
Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry.
ESC Heart Fail. 2022 Feb;9(1):408-419. doi: 10.1002/ehf2.13734. Epub 2021 Dec 31.
Zotero 插件